Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ProPhase pares costs, preps relaunches

This article was originally published in The Tan Sheet

Executive Summary

The OTC firm, formerly known as Quigley, discontinues a candy product line and shutters a contract manufacturing facility, reducing first-quarter operating costs and expenses 51 percent to $2.2 million. ProPhase Labs' net sales in the January-March period also dropped 50.4 percent to $2 million, but its year-over-year net loss was halved to $1.1 million. Sales took a hit as retailer orders of cold and flu products, such as ProPhase's Cold-EEZE zinc lozenges, were front-loaded in fourth quarter 2009, according to CEO Ted Karkus. He added May 17 ProPhase is entering "a wonderful new phase," with redesigned packaging, a new mint frost Cold-EEZE flavor and the planned reintroduction of a Kids-EEZE non-liquid product line (1"The Tan Sheet" May 10, 2010, In Brief)

You may also be interested in...

Cold-EEZE continues brand transformation

ProPhase Labs hires media solutions firm Women's Marketing Inc. to develop and implement multimedia campaigns for the Cold-EEZE and Kids-EEZE lozenge brands. Doylestown, Pa.-based ProPhase additionally announced details for its Kids-EEZE line extension of symptom-specific chews, including Allergy, Chest Congestion and Cough/Cold formulas. ProPhase already is revising its existing products' packaging and flavors (1"The Tan Sheet" May 24, 2010, In Brief). "We are excited to join with WMI to create a dynamic media campaign that will introduce our new and improved products to new consumers and reinvigorate our loyal customers," ProPhase CEO Ted Karkus said Sept. 7

Quigley now ProPhase Labs

The maker of Cold-EEZE zinc lozenges changes its name to ProPhase Labs Inc., following a shareholder vote May 5. Company shares now trade on NASDAQ under the symbol "PRPH." CEO Ted Karkus said the corporate re-branding will include redesigned packaging for Cold-EEZE and Kids-EEZE cold remedies. Since ousting founder Guy Quigley in June 2009, Karkus has shaken things up at the Doylestown, Pa., firm, including forming an OTC joint venture with delivery technology developer Phosphagenics (1"The Tan Sheet" March 29, 2010)

Sanofi Tries To Stop Lantus Biosimilar By Getting Supreme Court To Review PTAB, Again

Sanofi seeks to delay decision clearing path for Mylan's Lantus biosimilar; says it should be able to get rehearing based on Federal Circuit's ruling that PTAB judges were not constitutionally appointed.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts